FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Confirms Aricept 23 Approval

[ Price : $8.95]

FDA denies a Public Citizen petition asking that it withdraw Eisais Aricept 23 from the market.

Workshop on Outcome Metrics for Orthopedic Device Science

[ Price : $8.95]

Federal Register Notice: FDA plans a public workshop 11/27-28: Minimum Clinically Important Difference: An Outcome Metric in Ortho...

Workshop on Burkholderia Issues

[ Price : $8.95]

Federal Register Notice: FDA plans the public workshop 11/29-30 on exploring current issues and identifying regulatory science gap...

Boehringer Recalls 1 Pradaxa Lot Due to Packaging Defect

[ Price : $8.95]

Boehringer Ingelheim Pharmaceuticals recalls one lot of Pradaxa (dabigatran etexilate mesylate) 75mg due to a potential packaging ...

Arisaph Reports Positive Safety Results for Niacin Analog

[ Price : $8.95]

Arisaph Pharmaceuticals reports positive safety results from two trials of its niacin analog, ARI-3037MO in healthy volunteers.

Few Pediatric Trials Moving Overseas: FDA Study

[ Price : $8.95]

A study by FDAs Office of Pediatric Therapeutics finds that the U.S. continues to host the vast majority of pediatric clinical tri...

FDA Fast Track for Nektar Breast Cancer Therapy

[ Price : $8.95]

FDA designates fast track status for Nektar Therapeutics NKTR-102 (etirinotecan pegol) for treating patients with locally recurren...

Composition of CDER Exclusivity Board Unclear

[ Price : $8.95]

Attorney Kurt Karst says CDERs Exclusivity Board has been functioning for several months although the names of members have not be...

Stakeholders Praise, Pan UDI Proposal

[ Price : $8.95]

Stakeholders tell FDA they see the value in a medical device unique identifier but find problems with the agencys proposed regulat...

FDA Wont Revoke Daliresp Approval

[ Price : $8.95]

FDA denies a Physicians for Integrity in Medical Research petition to revoke approval of Daliresp.